Immune checkpoint molecules in neuroblastoma: A clinical perspective
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune checkpoint molecules in neuroblastoma: A clinical perspective
Authors
Keywords
-
Journal
SEMINARS IN CANCER BIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-07-04
DOI
10.1016/j.semcancer.2022.06.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
- (2022) Hirohito Yamaguchi et al. Nature Reviews Clinical Oncology
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
- (2021) Babak Moghimi et al. Nature Communications
- Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma
- (2021) Soheila Shirinbak et al. OncoImmunology
- The B7-H3-targeting antibody-drug conjugate m276-SL-PBD is potently effective against pediatric cancer preclinical solid tumor models
- (2021) Nathan M. Kendsersky et al. CLINICAL CANCER RESEARCH
- PD-L1 signaling on human memory CD4+ T cells induces a regulatory phenotype
- (2021) Giorgia Fanelli et al. PLOS BIOLOGY
- Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
- (2021) Alessandra Dondero et al. Journal for ImmunoTherapy of Cancer
- Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function
- (2021) Amy J. Petty et al. JCI Insight
- Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
- (2021) Meredith S. Irwin et al. JOURNAL OF CLINICAL ONCOLOGY
- NOX2-Deficient Neutrophils Facilitate Joint Inflammation Through Higher Pro-Inflammatory and Weakened Immune Checkpoint Activities
- (2021) Yi-Chu Liao et al. Frontiers in Immunology
- New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies
- (2021) Anup S. Pathania et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors
- (2020) Kirsty Ford et al. CANCER RESEARCH
- Potential role of the PD-L1 expression and tumor-infiltrating lymphocytes on neuroblastoma
- (2020) Shogo Zuo et al. PEDIATRIC SURGERY INTERNATIONAL
- B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression
- (2020) Ruoqin Wang et al. Cell Death & Disease
- Effects of anti-PD-1 immunotherapy on tumor regression: insights from a patient-derived xenograft model
- (2020) Asunción Martín-Ruiz et al. Scientific Reports
- Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma
- (2020) Karoline Ehlert et al. Journal for ImmunoTherapy of Cancer
- The role of NADPH oxidases in neuronal development
- (2020) Aslihan Terzi et al. FREE RADICAL BIOLOGY AND MEDICINE
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia
- (2020) Yuqing Dong et al. Frontiers in Immunology
- Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages
- (2020) Lydia Meziani et al. Journal for ImmunoTherapy of Cancer
- CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma
- (2020) Juliana Cano-Mejia et al. Translational Oncology
- PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
- (2020) Qi Peng et al. Nature Communications
- Revisiting the PD-1 pathway
- (2020) Nikolaos Patsoukis et al. Science Advances
- CD73+ Dendritic Cells in Cascading Th17 Responses of Experimental Autoimmune Uveitis-Induced Mice
- (2020) MinHee K. Ko et al. Frontiers in Immunology
- The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
- (2020) Judith Wienke et al. EUROPEAN JOURNAL OF CANCER
- Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells
- (2019) Fabio Morandi et al. OncoImmunology
- Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
- (2019) John Inge Johnsen et al. Frontiers in Molecular Neuroscience
- Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
- (2019) Hongwei Du et al. CANCER CELL
- Involvement of A3 Adenosine Receptor in Neuroblastoma Progression via Modulation of the Hypoxic/Angiogenic Pathway
- (2019) Grazia Maugeri et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study
- (2019) Morini et al. Cancers
- Activating killer cell immunoglobulin‐like receptors: Detection, function and therapeutic use
- (2019) Matthew D. Blunt et al. International Journal of Immunogenetics
- Mechanisms regulating PD-L1 expression on tumor and immune cells
- (2019) Shuming Chen et al. Journal for ImmunoTherapy of Cancer
- Adenosine Metabolism: Emerging Concepts for Cancer Therapy
- (2019) Detlev Boison et al. CANCER CELL
- NOX2-Dependent Reactive Oxygen Species Regulate Formyl-Peptide Receptor 1-Mediated TrkA Transactivation in SH-SY5Y Cells
- (2019) Martina Castaldo et al. Oxidative Medicine and Cellular Longevity
- Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
- (2019) Julie Voeller et al. Journal for ImmunoTherapy of Cancer
- Silencing of NADPH oxidase 4 attenuates hypoxia resistance in neuroblastoma cells SHSY-5Y by inhibiting PI3K/Akt-dependent glycolysis
- (2018) Ting Yu et al. ONCOLOGY RESEARCH
- PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease
- (2018) Priya Srinivasan et al. PLOS MEDICINE
- Altered Humoral Immune Responses and IgG Subtypes in NOX2-Deficient Mice and Patients: A Key Role for NOX2 in Antigen-Presenting Cells
- (2018) Julien Cachat et al. Frontiers in Immunology
- B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
- (2018) Peixin Dong et al. Frontiers in Oncology
- Clinical significance of serum soluble B7-H3 in patients with osteosarcoma
- (2018) Ling Wang et al. Cancer Cell International
- Pulmonary metastatic colonisation and granulomas in NOX2-deficient mice
- (2018) Louise van der Weyden et al. JOURNAL OF PATHOLOGY
- Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
- (2018) Noam Auslander et al. NATURE MEDICINE
- Human CD8+HLA-DR+ Regulatory T Cells, Similarly to Classical CD4+Foxp3+ Cells, Suppress Immune Responses via PD-1/PD-L1 Axis
- (2018) Andres Machicote et al. Frontiers in Immunology
- PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression
- (2018) Francesca R. Mariotti et al. OncoImmunology
- Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma
- (2017) Juliana Cano-Mejia et al. Nanomedicine-Nanotechnology Biology and Medicine
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States
- (2017) Diarmuid Coughlan et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Analysis of PD-1 expression in the monocyte subsets from non-septic and septic preterm neonates
- (2017) Magdalena Zasada et al. PLoS One
- Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma
- (2017) Valentina Rigo et al. Scientific Reports
- Role of NOX2-Derived Reactive Oxygen Species in NK Cell–Mediated Control of Murine Melanoma Metastasis
- (2017) Ebru Aydin et al. Cancer Immunology Research
- Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model
- (2017) Paola Bocca et al. OncoImmunology
- PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD2 antibody ch14.18/CHO
- (2017) Nikolai Siebert et al. OncoImmunology
- Gene expression of NOX family members and their clinical significance in hepatocellular carcinoma
- (2017) Hyuk Soo Eun et al. Scientific Reports
- Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
- (2016) Y. Mao et al. CLINICAL CANCER RESEARCH
- KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma
- (2016) Christopher J. Forlenza et al. JOURNAL OF CLINICAL ONCOLOGY
- Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes
- (2016) Tatsunori Goto et al. JOURNAL OF IMMUNOTHERAPY
- Dendritic Cell-Secreted Cytotoxic T-Lymphocyte-Associated Protein-4 Regulates the T-cell Response by Downmodulating Bystander Surface B7
- (2016) Matthew M. Halpert et al. STEM CELLS AND DEVELOPMENT
- Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade
- (2016) Nina Eissler et al. OncoImmunology
- Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway
- (2016) Chao Xie et al. Scientific Reports
- Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma
- (2015) Diana Seidel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Regulatory Role of Invariant NKT Cells in Tumor Immunity
- (2015) Rosanna M. McEwen-Smith et al. Cancer Immunology Research
- PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance
- (2015) Alessandra Dondero et al. OncoImmunology
- Vascular CD39/ENTPD1 Directly Promotes Tumor Cell Growth by Scavenging Extracellular Adenosine Triphosphate
- (2015) Lili Feng et al. NEOPLASIA
- NADPH Oxidases as Therapeutic Targets in Chronic Myelogenous Leukemia
- (2014) B. Sanchez-Sanchez et al. CLINICAL CANCER RESEARCH
- Direct T Cell Activation via CD40 Ligand Generates High Avidity CD8+ T Cells Capable of Breaking Immunological Tolerance for the Control of Tumors
- (2014) Ruey-Shyang Soong et al. PLoS One
- ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
- (2014) G Bianchi et al. Cell Death & Disease
- Adenosine production by human B cells and B cell-mediated suppression of activated T cells
- (2013) Z. Saze et al. BLOOD
- Immunomodulatory Monoclonal Antibodies Combined with Peptide Vaccination Provide Potent Immunotherapy in an Aggressive Murine Neuroblastoma Model
- (2013) E. L. Williams et al. CLINICAL CANCER RESEARCH
- Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression
- (2013) Danilo Marimpietri et al. PLoS One
- The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes
- (2013) Lena-Maria Carlson et al. OncoImmunology
- CCL2 is critical for immunosuppression to promote cancer metastasis
- (2012) Chie Kudo-Saito et al. CLINICAL & EXPERIMENTAL METASTASIS
- Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
- (2012) Nidale Tarek et al. JOURNAL OF CLINICAL INVESTIGATION
- Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
- (2012) Nai-Kong V. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Reactive Oxygen Species Regulate the Levels of Dual Oxidase (Duox1-2) in Human Neuroblastoma Cells
- (2012) Simona Damiano et al. PLoS One
- Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations
- (2012) Elio Schouppe et al. OncoImmunology
- B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
- (2011) Christina Tekle et al. INTERNATIONAL JOURNAL OF CANCER
- NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
- (2011) Ruth Esser et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
- (2011) Wendy B. London et al. JOURNAL OF CLINICAL ONCOLOGY
- Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes
- (2011) Felipe Saldanha-Araujo et al. Stem Cell Research
- Genotypes of NK Cell KIR Receptors, Their Ligands, and Fc Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy
- (2010) D. C. Delgado et al. CANCER RESEARCH
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion
- (2010) Sabine Huenecke et al. JOURNAL OF IMMUNOTHERAPY
- PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells
- (2010) Kim L Good-Jacobson et al. NATURE IMMUNOLOGY
- KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
- (2009) J. M. Venstrom et al. CLINICAL CANCER RESEARCH
- B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction
- (2009) Judith Leitner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- PD-1 signaling in primary T cells
- (2009) James L. Riley IMMUNOLOGICAL REVIEWS
- The extensive polymorphism of KIR genes
- (2009) Derek Middleton et al. IMMUNOLOGY
- Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
- (2009) R. Salcedo et al. JOURNAL OF IMMUNOLOGY
- PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
- (2009) S. Chikuma et al. JOURNAL OF IMMUNOLOGY
- Activation of antibacterial autophagy by NADPH oxidases
- (2009) J. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isolation of Neural Crest Derived Chromaffin Progenitors from Adult Adrenal Medulla
- (2009) Kuei-Fang Chung et al. STEM CELLS
- Neuroblastoma: Biology and staging
- (2009) Sabine Mueller et al. Current Oncology Reports
- Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule
- (2008) A Gregorio et al. HISTOPATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started